Introduction
Leading pharmaceutical firm has received a ₹24.06 crore contract from HSCC (India) Limited to supply essential medicines and diagnostic kits to Afghanistan, including packing, insurance, and delivery at the Technical Mission of India, Kabul.
Share price movement of Shukra Pharmaceuticals
On August 29, 2025, Shukra Pharmaceuticals Ltd opened at ₹26.22, up 1.98% from its previous close of ₹25.71. The stock recorded a high and low of ₹26.22. By 10:21 AM, it traded at ₹26.22 with a market cap of ₹1,148.12 crore.
Shukra Pharmaceuticals Bags ₹24 Crore Afghanistan Contract
Shukra Pharmaceuticals Limited has secured a contract from HSCC (India) Limited on behalf of the Ministry of External Affairs. The Letter of Award, dated August 28, 2025, is for supplying medicines and diagnostic kits to Afghanistan.
The contract is valued at ₹24.06 crore and includes packing, forwarding, insurance, and delivery at the consignee site in Kabul. Supplies will support the Technical Mission of India in Afghanistan.
Stock performance of Shukra Pharmaceuticals for Period of 1 week, 6 months, and 1 year
Shukra Pharmaceuticals Ltd delivered a 12.4% return over the past week, it gained 9.40% in the past six months. The stock surged 297% over the past year.
Also Read: Pharma stock: Gland pharma receives USFDA approval for vasopressin in 5% dextrose RTU injection
Shareholding pattern of Shukra Pharmaceuticals
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
| Promoter | 51.00% | 51.00% | 51.00% |
| FII | 0.00% | 0.00% | 0.00% |
| DII | 0.10% | 0.10% | 0.10% |
| Public | 48.90% | 48.90% | 48.90% |
About Shukra Pharmaceuticals
Shukra Pharmaceuticals Ltd (BSE: 524632), incorporated in 1993, is a WHO-GMP certified manufacturer of tablets, capsules, and small-volume parenterals, also engaged in laboratory testing and pharmaceutical product development and marketing.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
A: Shukra Pharmaceuticals Limited share price is rising after securing a ₹24.06 crore contract from HSCC (India) Limited to supply medicines and diagnostic kits to Afghanistan.
A: Shukra Pharmaceuticals Limited specializes in manufacturing and marketing pharmaceutical formulations like tablets, capsules, and small-volume parenterals, along with laboratory testing services.
A: The market capitalization of Shukra Pharmaceuticals Limited stands at ₹1,148.12 crore as of August 29, 2025.

